The Regulatory Bottleneck: Why American Sunscreens Lag Behind Europe’s Gold Standard

Strict FDA classifications of sunscreens as drugs have inadvertently created a public health gap, blocking advanced ingredients that offer superior UVA protection. This regulatory stagnation highlights how risk-averse policies can paradoxically increase health risks by preventing the adoption of more effective, cancer-preventing technologies available elsewhere.